Valiant Lab IPO subscribed 2
时间:2024-06-26 09:18:53 阅读(143)
The Initial Public Offering (IPO) of pharmaceutical ingredient manufacturing firm Valiant Laboratories was subscribed 2.17 times on the third day of bidding on Friday.
The initial share sale received bids for 1,65,77,925 shares against 76,23,030 shares on offer, as per NSE data.
Price range for the offer is Rs 133-140 a share.
The IPO is an entirely fresh issuance of up to 1.08 crore equity shares.
Proceeds of the issue will be utilised to set up a manufacturing facility for speciality chemicals in Gujarat through its subsidiary — Valiant Advanced Sciences Private Ltd — and to meet the working capital requirements of the subsidiary company.
Valiant Laboratories is an active pharmaceutical ingredient or bulk drug manufacturing company with its focus on manufacturing paracetamol, used in the treatment of headaches, muscle aches, arthritis, backache, toothache, cold and fever.
Unistone Capital is the manager to the offer.
Equity shares of the company will be listed on the BSE and the NSE.
上一篇:COP28 Climate Summit- PM Modi launches Green Credit Initiative, proposes Hosting COP33 – See Pics
下一篇:ZEEL, HDFC Bank, Axis Bank, Jindal Steel, Sanofi India, Titan stocks in focus
猜你喜欢
- Motisons Jewellers IPO receives 14
- Indian Airlines prompted to action- Boeing’s B737 Max fleet-wide inspection alert spurs safety measures
- India Exposition Mart gets SEBI’s nod for IPO; firm plans to raise Rs 450 crore via fresh equity
- Crude oil regains a bit of ground as Credit Suisse secures lifeline
- Indian businesses prepare for transformative 2024- 59% employees ready to incorporate AI into workplaces – There’s more
- NASA’s Artemis 2 Lunar Mission- A Celestial Journey with BTS Tunes
- Nafed sells chana below MSP to liquidate surplus stocks
- Mumbai-Ahmedabad bullet train project completes 100 per cent land acquisition! NHSRCL shares latest update on India’s ambitious mega project
- India-focused portfolio outperforms benchmarks- GREED & fear